Bahl & Gaynor Inc. trimmed its position in Agilent Technologies Inc (NYSE:A) by 2.1% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 19,300 shares of the medical research company’s stock after selling 410 shares during the period. Bahl & Gaynor Inc.’s holdings in Agilent Technologies were worth $1,382,000 at the end of the most recent quarter.

Other large investors have also recently made changes to their positions in the company. Rockefeller Capital Management L.P. increased its stake in Agilent Technologies by 45.2% during the 1st quarter. Rockefeller Capital Management L.P. now owns 3,825 shares of the medical research company’s stock worth $274,000 after purchasing an additional 1,190 shares in the last quarter. Swiss National Bank increased its stake in Agilent Technologies by 23.1% during the 1st quarter. Swiss National Bank now owns 1,201,083 shares of the medical research company’s stock worth $86,022,000 after purchasing an additional 225,300 shares in the last quarter. Zurich Insurance Group Ltd FI increased its stake in Agilent Technologies by 2.7% during the 1st quarter. Zurich Insurance Group Ltd FI now owns 296,438 shares of the medical research company’s stock worth $21,231,000 after purchasing an additional 7,770 shares in the last quarter. Franklin Resources Inc. increased its stake in Agilent Technologies by 2.0% during the 1st quarter. Franklin Resources Inc. now owns 1,451,418 shares of the medical research company’s stock worth $103,950,000 after purchasing an additional 28,151 shares in the last quarter. Finally, Mitsubishi UFJ Trust & Banking Corp increased its stake in Agilent Technologies by 3.4% during the 1st quarter. Mitsubishi UFJ Trust & Banking Corp now owns 290,506 shares of the medical research company’s stock worth $20,806,000 after purchasing an additional 9,466 shares in the last quarter.

A has been the subject of a number of research reports. UBS Group increased their target price on Agilent Technologies from $84.00 to $87.00 and gave the stock a “neutral” rating in a research note on Friday, May 22nd. Stifel Nicolaus lowered their target price on Agilent Technologies from $85.00 to $73.00 and set a “hold” rating for the company in a research note on Thursday, April 2nd. Wells Fargo & Co increased their target price on Agilent Technologies from $82.00 to $95.00 and gave the stock an “overweight” rating in a research note on Friday, May 22nd. Zacks Investment Research cut shares of Agilent Technologies from a “buy” rating to a “hold” rating and set a $89.00 price target for the company. in a research note on Friday, June 12th. Finally, Royal Bank of Canada assumed coverage on shares of Agilent Technologies in a research note on Tuesday, April 28th. They set a “sector perform” rating for the company. Eleven analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. The company presently has an average rating of “Hold” and a consensus price target of $85.75.

Agilent Technologies stock traded down $0.90 during mid-day trading on Friday, hitting $86.36. 78,729 shares of the company’s stock traded hands, compared to its average volume of 1,747,852. The firm has a 50 day simple moving average of $85.55 and a two-hundred day simple moving average of $81.55. Agilent Technologies Inc has a fifty-two week low of $61.13 and a fifty-two week high of $93.04. The stock has a market cap of $26.73 billion, a price-to-earnings ratio of 40.26, a P/E/G ratio of 2.78 and a beta of 1.13. The company has a debt-to-equity ratio of 0.38, a current ratio of 1.63 and a quick ratio of 1.24.

Agilent Technologies (NYSE:A) last announced its quarterly earnings results on Thursday, May 21st. The medical research company reported $0.71 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.61 by $0.10. The business had revenue of $1.24 billion during the quarter, compared to the consensus estimate of $1.20 billion. Agilent Technologies had a return on equity of 20.76% and a net margin of 13.04%. The company’s quarterly revenue was up .2% on a year-over-year basis. During the same quarter last year, the firm posted $0.71 EPS. On average, research analysts anticipate that Agilent Technologies Inc will post 3.11 earnings per share for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Wednesday, July 22nd. Investors of record on Tuesday, June 30th will be issued a dividend of $0.18 per share. The ex-dividend date of this dividend is Monday, June 29th. This represents a $0.72 annualized dividend and a yield of 0.83%. Agilent Technologies’s dividend payout ratio (DPR) is currently 23.15%.

In other Agilent Technologies news, SVP Dominique Grau sold 9,033 shares of the company’s stock in a transaction on Tuesday, May 26th. The stock was sold at an average price of $86.56, for a total value of $781,896.48. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Michael R. Mcmullen sold 8,814 shares of the company’s stock in a transaction on Monday, April 27th. The shares were sold at an average price of $76.20, for a total value of $671,626.80. Following the completion of the transaction, the chief executive officer now owns 542,848 shares of the company’s stock, valued at approximately $41,365,017.60. The disclosure for this sale can be found here. Insiders have sold 64,426 shares of company stock valued at $5,300,943 in the last quarter.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates through three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; laboratory software and information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies.

Read More: What is Elliott Wave theory?

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies Inc (NYSE:A).

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.